Steroidal saponins: Natural compounds with the potential to reverse tumor drug resistance (Review)
- Authors:
- Aiping Cui
- Hai Liu
- Xiaoxuan Liu
- Minhong Zhang
- Bang Xiao
- Biao Wang
- Jianqiong Yang
-
Affiliations: The Clinical Medicine Research Center of The First Clinical Medical College, Gannan Medical University, Ganzhou, Jiangxi 341000, P.R. China, The Clinical Medicine Research Center of The First Clinical Medical College, Gannan Medical University, Ganzhou, Jiangxi 341000, P.R. China - Published online on: October 3, 2024 https://doi.org/10.3892/ol.2024.14719
- Article Number: 585
-
Copyright: © Cui et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
 |
|
Brustugun OT, Moller B and Helland A: Years of life lost as a measure of cancer burden on a national level. Br J Cancer. 111:1014–1020. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Hofman M, Morrow GR, Roscoe JA, Hickok JT, Mustian KM, Moore DF, Wade JL and Fitch TR: Cancer patients' expectations of experiencing treatment-related side effects: A university of Rochester cancer center-community clinical oncology program study of 938 patients from community practices. Cancer. 101:851–857. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Wu Q, Yang Z, Nie Y, Shi Y and Fan D: Multi-drug resistance in cancer chemotherapeutics: Mechanisms and lab approaches. Cancer Lett. 347:159–166. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Bukowski K, Kciuk M and Kontek R: Mechanisms of multidrug resistance in cancer chemotherapy. Int J Mol Sci. 21:92482020. View Article : Google Scholar | |
|
Awad MG, Ali RA, Abd El-Monem DD, El-Magd MAJM and Toxicology C: Graviola leaves extract enhances the anticancer effect of cisplatin on various cancer cell lines. Mol Cell. 16:385–399. 2020. | |
|
Zhu X, Na X, Zeng Y, Xu Y, Chai D, Yang H, Miao J, Zhang Y, Yang F, Wang Y and Zhou Y: Polyphyllin I combined with doxorubicin shows chemosensitization effect in vivo and reduces immunotoxicity of doxorubicin. Mol Cell Toxicol. 18:359–369. 2022. View Article : Google Scholar | |
|
Sahu NP, Banerjee S, Mondal NB and Mandal D: Steroidal saponins. Fortschr Chem Org Naturst. 89:45–141. 2008.PubMed/NCBI | |
|
Sparg SG, Light ME and van Staden J: Biological activities and distribution of plant saponins. J Ethnopharmacol. 94:219–243. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Li M, Luo H, Huang Z, Qi J and Yu B: Screening and identification of Anti-inflammatory compounds from erdong gao via Multiple-target-cell extraction coupled with HPLC-Q-TOF-MS/MS and their Structure-activity relationship. Molecules. 28:2952022. View Article : Google Scholar : PubMed/NCBI | |
|
Passos FRS, Araújo-Filho HG, Monteiro BS, Shanmugam S, Araújo AAS, Almeida JRGDS, Thangaraj P, Júnior LJQ and Quintans JSS: Anti-inflammatory and modulatory effects of steroidal saponins and sapogenins on cytokines: A review of pre-clinical research. Phytomedicine. 96:1538422022. View Article : Google Scholar : PubMed/NCBI | |
|
Qin XJ, Sun DJ, Ni W, Yan H, Chen CX, Cheng YC, He L and Liu HY: Steroidal saponins with antimicrobial activity from stems and leaves of Paris polyphylla var. yunnanensis. Steroids. 77:1242–1248. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Pang X, Wan LF, Yang J, Bai PY, Zhang J, Chen XJ, Yan XL and Ma BP: Steroidal saponins from Trillium tschonoskii rhizome repress cancer stemness and proliferation of intrahepatic cholangiocarcinoma. Bioorg Chem. 121:1056792022. View Article : Google Scholar : PubMed/NCBI | |
|
Xiang YC, Peng P, Liu XW, Jin X, Shen J, Zhang T, Zhang L, Wan F, Ren YL, Yu QQ, et al: Paris saponin VII, a Hippo pathway activator, induces autophagy and exhibits therapeutic potential against human breast cancer cells. Acta Pharmacol Sin. 43:1568–1580. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Chien HJ, Liu CJ, Ying TH, Wu PJ, Wang JW, Ting YH, Hsieh YH and Wang SC: Timosaponin AIII inhibits migration and invasion abilities in human cervical cancer cells through inactivation of p38 MAPK-Mediated uPA expression in vitro and in vivo. Cancers (Basel). 15:372022. View Article : Google Scholar : PubMed/NCBI | |
|
Yang J, Cao L, Li Y, Liu H, Zhang M, Ma H, Wang B, Yuan X and Liu Q: Gracillin isolated from reineckia carnea induces apoptosis of A549 cells via the mitochondrial pathway. Drug Des Devel Ther. 15:233–243. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Yu J, Deng H and Xu Z: Targeting macrophage priming by polyphyllin VII triggers anti-tumor immunity via STING-governed cytotoxic T-cell infiltration in lung cancer. Sci Rep. 10:213602020. View Article : Google Scholar : PubMed/NCBI | |
|
Zeng KW, Song FJ, Li N, Dong X, Jiang Y and Tu PF: ASC, a bioactive steroidal saponin from Ophitopogin japonicas, inhibits angiogenesis through interruption of Src tyrosine kinase-dependent matrix metalloproteinase pathway. Basic Clin Pharmacol Toxicol. 116:115–123. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang H, Xu J, Wang M, Xia X, Dai R and Zhao Y: Steroidal saponins and sapogenins from fenugreek and their inhibitory activity against α-glucosidase. Steroids. 161:1086902020. View Article : Google Scholar : PubMed/NCBI | |
|
Li W, Ji L, Tian J, Tang W, Shan X, Zhao P, Chen H, Zhang C, Xu M, Lu R and Guo W: Ophiopogonin D alleviates diabetic myocardial injuries by regulating mitochondrial dynamics. J Ethnopharmacol. 271:1138532021. View Article : Google Scholar : PubMed/NCBI | |
|
Li X, Huang L, Kong L, Su Y, Zhou H, Ji P, Sun R, Wang C and Li W and Li W: Ginsenoside Rg1 alleviates learning and memory impairments and Aβ disposition through inhibiting NLRP1 inflammasome and autophagy dysfunction in APP/PS1 mice. Mol Med Rep. 27:62023. View Article : Google Scholar : PubMed/NCBI | |
|
Bai C, Yang X, Zou K, He H, Wang J, Qin H, Yu X, Liu C, Zheng J, Cheng F and Chen J: Anti-proliferative effect of RCE-4 from Reineckia carnea on human cervical cancer HeLa cells by inhibiting the PI3K/Akt/mTOR signaling pathway and NF-κB activation. Naunyn Schmiedebergs Arch Pharmacol. 389:573–584. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Chen L, Cheng CS, Gao H, Zhan L, Wang F, Qu C, Li Y, Wang P, Chen H, Meng Z, et al: Natural compound methyl protodioscin suppresses proliferation and inhibits glycolysis in pancreatic cancer. Evid Based Complement Alternat Med. 2018:73430902018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao YZ, Zhang YY, Han H, Fan RP, Hu Y, Zhong L, Kou JP and Yu BY: Advances in the antitumor activities and mechanisms of action of steroidal saponins. Chin J Nat Med. 16:732–748. 2018.PubMed/NCBI | |
|
Auyeung KK, Law PC and Ko JK: Combined therapeutic effects of vinblastine and Astragalus saponins in human colon cancer cells and tumor xenograft via inhibition of tumor growth and proangiogenic factors. Nutr Cancer. 66:662–674. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Gillet JP and Gottesman MM: Mechanisms of multidrug resistance in cancer. Methods Mol Biol. 596:47–76. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Wang X, Zhang H and Chen X: Drug resistance and combating drug resistance in cancer. Cancer Drug Resist. 2:141–160. 2019.PubMed/NCBI | |
|
Bungaro M, Buttigliero C and Tucci M: Overcoming the mechanisms of primary and acquired resistance to new generation hormonal therapies in advanced prostate cancer: Focus on androgen receptor independent pathways. Cancer Drug Resist. 3:726–741. 2020.PubMed/NCBI | |
|
Yuan R, Hou Y, Sun W, Yu J, Liu X, Niu Y, Lu JJ and Chen X: Natural products to prevent drug resistance in cancer chemotherapy: A review. Ann NY Acad Sci. 1401:19–27. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Vasan N, Baselga J and Hyman DM: A view on drug resistance in cancer. Nature. 575:299–309. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Gonçalves AC, Richiardone E, Jorge J, Polónia B, Xavier CPR, Salaroglio IC, Riganti C, Vasconcelos MH, Corbet C and Sarmento-Ribeiro AB: Impact of cancer metabolism on therapy Resistance-clinical implications. Drug Resist Updat. 59:1007972021. View Article : Google Scholar : PubMed/NCBI | |
|
Kalbasi A and Ribas A: Tumour-intrinsic resistance to immune checkpoint blockade. Nat Rev Immunol. 20:25–39. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Cucolo L, Chen Q, Qiu J, Yu Y, Klapholz M, Budinich KA, Zhang Z, Shao Y, Brodsky IE, Jordan MS, et al: The interferon-stimulated gene RIPK1 regulates cancer cell intrinsic and extrinsic resistance to immune checkpoint blockade. Immunity. 55:671–685.e10. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Sun Y, Li X, Cheng H, Wang S, Zhou D, Ding J and Ma F: Drug resistance and new therapies in gallbladder cancer. Drug Discov Ther. 17:220–229. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Jaromi L, Csongei V, Vesel M, Abdelwahab EMM, Soltani A, Torok Z, Smuk G, Sarosi V and Pongracz JE: KRAS and EGFR mutations differentially alter ABC drug transporter expression in Cisplatin-resistant non-small cell lung cancer. Int J Mol Sci. 22:53842021. View Article : Google Scholar : PubMed/NCBI | |
|
Arcila ME, Chaft JE, Nafa K, Roy-Chowdhuri S, Lau C, Zaidinski M, Paik PK, Zakowski MF, Kris MG and Ladanyi M: Prevalence, clinicopathologic associations, and molecular spectrum of ERBB2 (HER2) tyrosine kinase mutations in lung adenocarcinomas. Clin Cancer Res. 18:4910–4918. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Tanaka N, Lin JJ, Li C, Ryan MB, Zhang J, Kiedrowski LA, Michel AG, Syed MU, Fella KA, Sakhi M, et al: Clinical acquired resistance to KRAS(G12C) inhibition through a novel KRAS Switch-II pocket mutation and polyclonal alterations converging on RAS-MAPK reactivation. Cancer Dis. 11:1913–1922. 2021. View Article : Google Scholar | |
|
Cooper AJ, Sequist LV and Lin JJ: Third-generation EGFR and ALK inhibitors: Mechanisms of resistance and management. Nat Rev Clin Oncol. 19:499–514. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Jie G, Yijiang J, Ayijiang Ye L and Yuji W: Research progress of tumor multi-resistance mechanism and reversal of resistance. Modern Oncol. 30:3991–3995. 2022. | |
|
Pastushenko I and Blanpain C: EMT transition states during tumor progression and metastasis. Trends Cell Biol. 29:212–226. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Minko T, Rodriguez-Rodriguez L and Pozharov V: Nanotechnology approaches for personalized treatment of multidrug resistant cancers. Advanced drug delivery reviews. 65:1880–1895. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Mariño G, Niso-Santano M, Baehrecke EH and Kroemer G: Self-consumption: The interplay of autophagy and apoptosis. Nat Rev Mol Cell Biol. 15:81–94. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Wu A, Jia Y, Dong B, Tang L, Liu Y, Du H, Yuan P, Dong P and Ji J: Apoptosis and KI 67 index correlate with preoperative chemotherapy efficacy and better predict the survival of gastric cancer patients with combined therapy. Cancer Chemother Pharmacol. 73:885–893. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Ferrari P, Scatena C, Ghilli M, Bargagna I, Lorenzini G and Nicolini A: Molecular mechanisms, biomarkers and emerging therapies for chemotherapy resistant TNBC. Int J Mol Sci. 23:16652022. View Article : Google Scholar : PubMed/NCBI | |
|
Plati J, Bucur O and Khosravi-Far R: Dysregulation of apoptotic signaling in cancer: Molecular mechanisms and therapeutic opportunities. J Cell Biochem. 104:1124–1149. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Kaloni D, Diepstraten ST, Strasser A and Kelly GL: BCL-2 protein family: Attractive targets for cancer therapy. Apoptosis. 28:20–38. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Nicholson DW: From bench to clinic with Apoptosis-based therapeutic agents. Nature. 407:810–816. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Li YJ, Lei YH, Yao N, Wang CR, Hu N, Ye WC, Zhang DM and Chen ZS: Autophagy and multidrug resistance in cancer. Chi J Cancer. 36:522017. View Article : Google Scholar | |
|
Chiang HL, Terlecky SR, Plant CP and Dice JF: A role for a 70-kilodalton heat shock protein in lysosomal degradation of intracellular proteins. Science. 246:382–385. 1989. View Article : Google Scholar : PubMed/NCBI | |
|
Poillet-Perez L and White E: Role of tumor and host autophagy in cancer metabolism. Genes Dev. 33:610–619. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Hardie DG: AMPK: Positive and negative regulation, and its role in whole-body energy homeostasis. Curr Opin Cell Biol. 33:1–7. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Nguyen HG, Yang JC, Kung HJ, Shi XB, Tilki D, Lara PN Jr, DeVere White RW, Gao AC and Evans CP: Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model. Oncogene. 33:4521–4530. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Chen K and Shi W: Autophagy regulates resistance of non-small cell lung cancer cells to paclitaxel. Tumour Biol. 37:10539–10544. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Liu J, Deng X, Sun X, Dong J and Huang J: Inhibition of autophagy enhances timosaponin AIII-induced lung cancer cell apoptosis and anti-tumor effect in vitro and in vivo. Life Sci. 257:1180402020. View Article : Google Scholar : PubMed/NCBI | |
|
Brabletz T, Kalluri R, Nieto MA and Weinberg RA: EMT in cancer. Nat Rev Cancer. 18:128–134. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Mashouri L, Yousefi H, Aref AR, Ahadi AM, Molaei F and Alahari SK: Exosomes: Composition, biogenesis, and mechanisms in cancer metastasis and drug resistance. Mol Cancer. 18:752019. View Article : Google Scholar : PubMed/NCBI | |
|
Nieto MA, Huang RY, Jackson RA and Thiery JP: EMT: 2016. Cell. 166:21–45. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
De Craene B and Berx G: Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer. 13:97–110. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Shibue T and Weinberg RA: EMT, CSCs, and drug resistance: The mechanistic link and clinical implications. Nat Rev Clin Oncol. 14:611–629. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Duan H, Liu Y, Gao Z and Huang W: Recent advances in drug delivery systems for targeting cancer stem cells. Acta Pharm Sin B. 11:55–70. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Du B and Shim JS: Targeting Epithelial-Mesenchymal transition (EMT) to overcome drug resistance in cancer. Molecules. 21:9652016. View Article : Google Scholar : PubMed/NCBI | |
|
Yan LL, Zhang YJ, Gao WY, Man SL and Wang Y: In vitro and in vivo anticancer activity of steroid saponins of Paris polyphylla var. yunnanensis. Exp Oncol. 31:27–32. 2009.PubMed/NCBI | |
|
Dean M, Rzhetsky A and Allikmets R: The human ATP-binding cassette (ABC) transporter superfamily. Genome Res. 11:1156–1166. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Wu CP, Hsiao SH, Huang YH, Hung LC, Yu YJ, Chang YT, Hung TH and Wu YS: Sitravatinib sensitizes ABCB1- and ABCG2-Overexpressing Multidrug-resistant cancer cells to chemotherapeutic drugs. Cancers. 12:1952020. View Article : Google Scholar : PubMed/NCBI | |
|
Gu J, Huang W, Wang X, Zhang J, Tao T, Zheng Y, Liu S, Yang J, Chen ZS, Cai CY, et al: Hsa-miR-3178/RhoB/PI3K/Akt, a novel signaling pathway regulates ABC transporters to reverse gemcitabine resistance in pancreatic cancer. Mol Cancer. 21:1122022. View Article : Google Scholar : PubMed/NCBI | |
|
Luo Q, Du R, Liu W, Huang G, Dong Z and Li X: PI3K/Akt/mTOR signaling pathway: Role in esophageal squamous cell carcinoma, regulatory mechanisms and opportunities for targeted therapy. Front Oncol. 12:8523832022. View Article : Google Scholar : PubMed/NCBI | |
|
Ersahin T, Tuncbag N and Cetin-Atalay R: The PI3K/AKT/mTOR interactive pathway. Mol Biosyst. 11:1946–1954. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Xu F, Na L, Li Y and Chen L: Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours. Cell Biosci. 10:542020. View Article : Google Scholar : PubMed/NCBI | |
|
Asati V, Mahapatra DK and Bharti SK: PI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathways inhibitors as anticancer agents: Structural and pharmacological perspectives. Eur J Med Chem. 109:314–341. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Mendoza MC, Er EE and Blenis J: The Ras-ERK and PI3K-mTOR pathways: Cross-talk and compensation. Trends Biochem Sci. 36:320–328. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Shafei MA, Forshaw T, Davis J, Flemban A, Qualtrough D, Dean S, Perks C, Dong M, Newman R and Conway ME: BCATc modulates crosstalk between the PI3K/Akt and the Ras/ERK pathway regulating proliferation in triple negative breast cancer. Oncotarget. 11:1971–1987. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Lin Y, Zhao WR, Shi WT, Zhang J, Zhang KY, Ding Q, Chen XL, Tang JY and Zhou ZY: Pharmacological activity, pharmacokinetics, and toxicity of Timosaponin AIII, a natural product isolated from Anemarrhena asphodeloides Bunge: A review. Front Pharmacol. 11:7642020. View Article : Google Scholar : PubMed/NCBI | |
|
MarElia CB, Sharp AE, Shemwell TA, Clare Zhang Y and Burkhardt BR: Anemarrhena asphodeloides Bunge and its constituent timosaponin-AIII induce cell cycle arrest and apoptosis in pancreatic cancer cells. FEBS Open Bio. 8:1155–1166. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Song XY, Han FY, Chen JJ, Wang W, Zhang Y, Yao GD and Song SJ: Timosaponin AIII, a steroidal saponin, exhibits anti-tumor effect on taxol-resistant cells in vitro and in vivo. Steroids. 146:57–64. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Thapa CB, Paudel MR, Bhattarai HD, Pant KK, Devkota HP, Adhikari YP and Pant B: Bioactive secondary metabolites in Paris polyphylla Sm. and their biological activities: A review. Heliyon. 8:e089822022. View Article : Google Scholar : PubMed/NCBI | |
|
Yang Q, Chen W, Xu Y, Lv X, Zhang M and Jiang H: Polyphyllin I modulates MALAT1/STAT3 signaling to induce apoptosis in gefitinib-resistant non-small cell lung cancer. Toxicol Appl Pharmacol. 356:1–7. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zheng R, Jiang H, Li J, Liu X and Xu H: Polyphyllin II restores sensitization of the resistance of PC-9/ZD Cells to gefitinib by a negative regulation of the PI3K/Akt/mTOR signaling pathway. Curr Cancer Drug Targets. 17:376–385. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Liu Y, Wang M, Liu K, Qiu P, Zhang S, Lu Y, Tang N and Tang H: New steroidal saponins from the rhizomes of Paris vietnamensis and their cytotoxicity. Molecules. 23:5882018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang S, Lu Y, Li H, Ji Y, Fang F, Tang H and Qiu P: A steroidal saponin form Paris vietnamensis (Takht.) reverses temozolomide resistance in glioblastoma cells via inducing apoptosis through ROS/PI3K/Akt pathway. Biosci Trends. 14:123–133. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Song S, Du L, Jiang H, Zhu X, Li J and Xu J: Paris Saponin I sensitizes gastric cancer cell lines to cisplatin via cell cycle arrest and apoptosis. Med Sci Monit. 22:3798–3803. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Liu Z, Zheng Q, Chen W, Wu M, Pan G, Yang K, Li X, Man S, Teng Y, Yu P and Gao W: Chemosensitizing effect of Paris Saponin I on Camptothecin and 10-hydroxycamptothecin in lung cancer cells via p38 MAPK, ERK, and Akt signaling pathways. Eur J Med Chem. 125:760–769. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Chen Y, Zhang Y, Song W, Zhang Y, Dong X and Tan M: Ginsenoside Rh2 improves the cisplatin Anti-tumor effect in lung adenocarcinoma A549 cells via superoxide and PD-L1. Anticancer Agents Med Chem. 20:495–503. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Kim DG, Jung KH, Lee DG, Yoon JH, Choi KS, Kwon SW, Shen HM, Morgan MJ, Hong SS and Kim YS: 20(S)-Ginsenoside Rg3 is a novel inhibitor of autophagy and sensitizes hepatocellular carcinoma to doxorubicin. Oncotarget. 5:4438–4451. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Yuan Z, Jiang H, Zhu X, Liu X and Li J: Ginsenoside Rg3 promotes cytotoxicity of Paclitaxel through inhibiting NF-κB signaling and regulating Bax/Bcl-2 expression on triple-negative breast cancer. Biomed Pharmacother. 89:227–232. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Wang L, Li X, Song YM, Wang B, Zhang FR, Yang R, Wang HQ and Zhang GJ: Ginsenoside Rg3 sensitizes human non-small cell lung cancer cells to γ-radiation by targeting the nuclear factor-κB pathway. Mol Med Rep. 12:609–614. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Chhon S, Jeon J, Kim J and Park SU: Accumulation of anthocyanins through overexpression of AtPAP1 in Solanum nigrum lin. (Black Nightshade). Biomolecules. 10:2772020. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Xu J, Wang Y, Xiang L and He X: S-20, a steroidal saponin from the berries of black nightshade, exerts anti-multidrug resistance activity in K562/ADR cells through autophagic cell death and ERK activation. Food Funct. 13:2200–2215. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Wang S, Xu J, Wang Y, Xiang L and He X: Total steroidal saponins from black nightshade (Solanum nigrum L.) overcome tumor multidrug resistance by inducing autophagy-mediated cell death in vivo and in vitro. Phytother Res. 37:3009–3024. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Wang S, Wang L, Xu J, Wang Y, Xiang L and He X: Synergistic combination of the total steroidal saponins from the berries of black nightshade and Adriamycin to overcome leukemia multidrug resistance. J Agric Food Chem. Feb 8–2023.doi: 10.1021/acs.jafc.2c07740 (Epub ahead of print). | |
|
Lou W, Chen Y, Zhu KY, Deng H, Wu T and Wang J: Polyphyllin I overcomes EMT-Associated resistance to erlotinib in lung cancer cells via IL-6/STAT3 pathway inhibition. Biol Pharm Bull. 40:1306–1313. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Feng FF, Cheng P, Sun C, Wang H and Wang W: Inhibitory effects of polyphyllins I and VII on human cisplatin-resistant NSCLC via p53 upregulation and CIP2A/AKT/mTOR signaling axis inhibition. Chin J Nat Med. 17:768–777. 2019.PubMed/NCBI | |
|
Bhuvanalakshmi G, Basappa Rangappa KS, Dharmarajan A, Sethi G, Kumar AP and Warrier S: Breast cancer stem-like cells are inhibited by diosgenin, a steroidal saponin, by the attenuation of the wnt β-Catenin signaling via the wnt antagonist secreted frizzled related Protein-4. Front Pharmacol. 8:1242017. View Article : Google Scholar : PubMed/NCBI | |
|
Chen JR, Jia XH, Wang H, Yi YJ, Wang JY and Li YJ: Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway. Int J Oncol. 48:2063–2070. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Xie Y, Yan X and Sun L: The mechanism of Bufalin-induced apoptosis of K562/A02. Med Sci Monit. 25:2542–2552. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Wang G, Tang X, Zhao F, Qin X, Wang F, Yang D, Zhu H and Chen X: Total saponins from Trillium tschonoskii maxim promote neurological recovery in model rats with Post-stroke cognitive impairment. Front Pharmacol. 14:12555602023. View Article : Google Scholar : PubMed/NCBI | |
|
Wang H, Zhai Z, Li N, Jin H, Chen J, Yuan S, Wang L, Zhang J, Li Y, Yun J, et al: Steroidal saponin of Trillium tschonoskii. Reverses multidrug resistance of hepatocellular carcinoma. Phytomedicine. 20:985–991. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Li Y, Sun Y, Tang T, Niu Y, Li X, Xie M, Jin H and Mei Q: Paris saponin VII reverses chemoresistance in breast MCF-7/ADR cells. J Ethnopharmacol. 232:47–54. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Tang GE, Niu YX, Li Y, Wu CY, Wang XY and Zhang J: Paris saponin VII enhanced the sensitivity of HepG2/ADR cells to ADR via modulation of PI3K/AKT/MAPK signaling pathway. Kaohsiung J Med Sci. 36:98–106. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Wang H, Fei Z and Jiang H: Polyphyllin VII increases sensitivity to gefitinib by modulating the elevation of P21 in acquired gefitinib resistant non-small cell lung cancer. J Pharmacol Sci. 134:190–196. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Chai D, Yuan J, Zhu X, Zeng Y, Yang R, Chen Y, Wang Y and Zhou Y: Total Saponins from paris forrestii reverse multidrug resistance of MCF-7/ADM cells by suppression of P-gp via ERK signaling pathway. Biol Pharm Bull. 43:1823–1830. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Yang L, Zhang C, Chen J, Zhang S, Pan G, Xin Y, Lin L and You Z: Shenmai injection suppresses multidrug resistance in MCF-7/ADR cells through the MAPK/NF-κB signalling pathway. Pharma Biol. 58:276–285. 2020. View Article : Google Scholar | |
|
Yu J, Xin YF, Gu LQ, Gao HY, Xia LJ, You ZQ, Xie F, Ma ZF, Wang Z and Xuan YX: One-month toxicokinetic study of SHENMAI injection in rats. J Ethnopharmacol. 154:391–399. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Siddiqi MH, Siddiqi MZ, Ahn S, Kang S, Kim YJ, Sathishkumar N, Yang DU and Yang DC: Ginseng saponins and the treatment of osteoporosis: Mini literature review. J Ginseng Res. 37:261–268. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Lyu CG, Kang CZ, Kang LP, Yang J, Wang S, He YL, Deng AP, Wang HY, Huang LQ and Guo LP: Structural characterization and discrimination of Ophiopogon japonicas (Liliaceae) from different geographical origins based on metabolite profiling analysis. J Pharm Biomed Anal. 185:1132122020. View Article : Google Scholar : PubMed/NCBI | |
|
Mbaveng AT, Chi GF, Nguenang GS, Abdelfatah S, Tchangna Sop RV, Ngadjui BT, Kuete V and Efferth T: Cytotoxicity of a naturally occuring spirostanol saponin, progenin III, towards a broad range of cancer cell lines by induction of apoptosis, autophagy and necroptosis. Chem Biol Interact. 326:1091412020. View Article : Google Scholar : PubMed/NCBI | |
|
Saxena M, Stephens MA, Pathak H and Rangarajan A: Transcription factors that mediate epithelial-mesenchymal transition lead to multidrug resistance by upregulating ABC transporters. Cell Death Dis. 2:e1792011. View Article : Google Scholar : PubMed/NCBI | |
|
Lee WK and Kolesnick RN: Sphingolipid abnormalities in cancer multidrug resistance: Chicken or egg? Cell Signal. 38:134–145. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Brachtendorf S, Wanger RA, Birod K, Thomas D, Trautmann S, Wegner MS, Fuhrmann DC, Brüne B, Geisslinger G and Grösch S: Chemosensitivity of human colon cancer cells is influenced by a p53-dependent enhancement of ceramide synthase 5 and induction of autophagy. Biochim Biophys Acta Mol Cell Biol Lipid. 1863:1214–1227. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Rivel T, Ramseyer C and Yesylevskyy S: The asymmetry of plasma membranes and their cholesterol content influence the uptake of cisplatin. Sci Rep. 9:56272019. View Article : Google Scholar : PubMed/NCBI | |
|
Gelsomino G, Corsetto PA, Campia I, Montorfano G, Kopecka J, Castella B, Gazzano E, Ghigo D, Rizzo AM and Riganti C: Omega 3 fatty acids chemosensitize multidrug resistant colon cancer cells by down-regulating cholesterol synthesis and altering detergent resistant membranes composition. Mol Cancer. 12:1372013. View Article : Google Scholar : PubMed/NCBI | |
|
Bernardes N and Fialho AM: Perturbing the dynamics and organization of cell membrane components: A new paradigm for Cancer-Targeted therapies. Int J Mol Sci. 19:38712018. View Article : Google Scholar : PubMed/NCBI | |
|
Zalba S and Ten Hagen TL: Cell membrane modulation as adjuvant in cancer therapy. Cancer Treat Rev. 52:48–57. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Golombek SK, May JN, Theek B, Appold L, Drude N, Kiessling F and Lammers T: Tumor targeting via EPR: Strategies to enhance patient responses. Adv Drug Deliv Rev. 130:17–38. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Yao J, Man S, Dong H, Yang L, Ma L and Gao W: Combinatorial treatment of Rhizoma Paridis saponins and sorafenib overcomes the intolerance of sorafenib. J Steroid Biochem Mol Biol. 183:159–166. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Liu H, Yang J, Li L, Shi W, Yuan X and Wu L: The natural occurring compounds targeting endoplasmic reticulum stress. Evid Based Complement Alternat Med. 2016:78312822016. View Article : Google Scholar : PubMed/NCBI | |
|
Man S, Lv P, Cui J, Liu F, Peng L, Ma L, Liu C and Gao W: Paris saponin II-induced paraptosis-associated cell death increased the sensitivity of cisplatin. Toxicol Appl Pharmacol. 406:1152062020. View Article : Google Scholar : PubMed/NCBI | |
|
Zou P, Chen Z, He Q and Zhuo Y: Polyphyllin I induces ferroptosis in castration-resistant prostate cancer cells through the ERK/DNMT1/ACSL4 axis. Prostate. 84:64–73. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Bai S, Sun Y, Cheng Y, Ye W, Jiang C, Liu M, Ji Q, Zhang B, Mei Q, Liu D and Zhou S: MCP mediated active targeting calcium phosphate hybrid nanoparticles for the treatment of orthotopic drug-resistant colon cancer. J Nanobiotechnology. 19:3672021. View Article : Google Scholar : PubMed/NCBI | |
|
He DX, Li GH, Gu XT, Zhang L, Mao AQ, Wei J, Liu DQ, Shi GY and Ma X: A new agent developed by biotransformation of polyphyllin VII inhibits chemoresistance in breast cancer. Oncotarget. 7:31814–31824. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Upadhyay S, Jeena GS and Shikha Shukla RK: Recent advances in steroidal saponins biosynthesis and in vitro production. Planta. 248:519–544. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Asgaritarghi G, Farsani SSM, Sadeghizadeh D, Najafi F and Sadeghizadeh M: Anti-Cancer role of dendrosomal nano solanine in chronic myelogenous leukemia cell line through attenuation of PI3K/AKT/mTOR signaling pathway and inhibition of hTERT expression. Curr Mol Pharmacol. 16:592–608. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Liu G, Feng S, Sui M, Chen B and Sun P: Extraction and identification of steroidal saponins from Polygonatum cyrtonema Hua using natural deep eutectic solvent-synergistic quartz sand assisted extraction method. J Sep Sci. 46:e22008232023. View Article : Google Scholar : PubMed/NCBI | |
|
Maliwong J, Chimnoi N, Thamniyom W, Ruchirawat S and Kanchanapoom TJPL: Steroidal saponins from the rhizomes of Tacca integrifolia. Phytochemistry Lett. 53:66–72. 2023. View Article : Google Scholar |
